Literature DB >> 11459773

Vascular function and blood pressure in GH transgenic mice.

M Bohlooly-Y1, L Carlson, B Olsson, H Gustafsson, I J Andersson, J Törnell, G Bergström.   

Abstract

Acromegaly is associated with cardiovascular disease. We studied vascular function and mean arterial blood pressure in transgenic mice overexpressing bovine GH. Mean arterial blood pressure was measured in conscious, unrestrained male and female bovine GH and littermate control mice during normal as well as high salt intake using telemetric devices. Structure in artificially perfused maximally dilated hindquarter vascular beds and vascular reactivity and endothelial function in small mesenteric vessels were studied in female bovine GH and control mice. Mean arterial blood pressure was increased in female bovine GH transgenic (126 +/- 3 mm Hg) and male bovine GH transgenic (129 +/- 4 mm Hg) compared with female (109 +/- 3 mm Hg, P < 0.05) and male (111 +/- 3 mm Hg, P < 0.05) controls respectively. Increased salt intake had no effect on mean arterial blood pressure. Perfusion studies showed a significant decrease in the average diameter of the female bovine GH transgenic hindquarter vascular bed (P < 0.05). The responses of isolated resistance arteries to nor-epinephrine, potassium-induced depolarization, acetylcholine, or sodium-nitroprusside did not significantly differ between bovine GH transgenic and control mice. We conclude that the phenotype of the bovine GH transgenic mice includes a salt-resistant form of hypertension. Furthermore, the increase in mean arterial blood pressure is accompanied by a significant structural narrowing of the resistance vasculature without changes in vascular reactivity or endothelial function. The results imply that hypertension in bovine GH transgenic mice is maintained mainly by a structurally based increase in peripheral vascular resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459773     DOI: 10.1210/endo.142.8.8296

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues.

Authors:  M C De Martino; R S Auriemma; G Brevetti; G Vitale; V Schiano; M Galdiero; L Grasso; G Lombardi; A Colao; R Pivonello
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

2.  Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine.

Authors:  Hans H Dietrich; Dana R Abendschein; Sung Ho Moon; Neema Nayeb-Hashemi; David J Mancuso; Christopher M Jenkins; Kevin M Kaltenbronn; Kendall J Blumer; John Turk; Richard W Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

3.  The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.

Authors:  Carmen Gonzalez; Hector Rosas-Hernandez; Brenda Jurado-Manzano; Manuel Alejandro Ramirez-Lee; Samuel Salazar-Garcia; Pedro Pablo Martinez-Cuevas; Aída Jimena Velarde-Salcedo; Humberto Morales-Loredo; Ricardo Espinosa-Tanguma; Syed F Ali; Rafael Rubio
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

Review 4.  Vascular failure: a hypothesis.

Authors:  Stephen M Schwartz; Randolph L Geary; Lawrence D Adams
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

5.  Insulin signaling in the heart is impaired by growth hormone: a direct and early event.

Authors:  Marina C Muñoz; Verónica G Piazza; Valeria Burghi; Jorge F Giani; Carolina S Martinez; Nadia S Cicconi; Nadia V Muia; Yimin Fang; Sergio Lavandero; Ana I Sotelo; Andrzej Bartke; Patricia A Pennisi; Fernando P Dominici; Johanna G Miquet
Journal:  J Mol Endocrinol       Date:  2022-06-23       Impact factor: 4.869

6.  Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study.

Authors:  Pär Sparén; Denny Vågerö; Dmitri B Shestov; Svetlana Plavinskaja; Nina Parfenova; Valeri Hoptiar; Dominique Paturot; Maria Rosaria Galanti
Journal:  BMJ       Date:  2003-12-05

7.  Elevated systolic blood pressure in male GH transgenic mice is age dependent.

Authors:  Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

8.  Cardiac-Specific Disruption of GH Receptor Alters Glucose Homeostasis While Maintaining Normal Cardiac Performance in Adult Male Mice.

Authors:  Adam Jara; Xingbo Liu; Don Sim; Chance M Benner; Silvana Duran-Ortiz; Yanrong Qian; Edward O List; Darlene E Berryman; Jason K Kim; John J Kopchick
Journal:  Endocrinology       Date:  2016-04-01       Impact factor: 4.736

9.  Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.

Authors:  Jorge F Giani; Johanna G Miquet; Marina C Muñoz; Valeria Burghi; Jorge E Toblli; Michal M Masternak; John J Kopchick; Andrzej Bartke; Daniel Turyn; Fernando P Dominici
Journal:  Growth Horm IGF Res       Date:  2012-09-02       Impact factor: 2.372

Review 10.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.